
Saral Dinesh Shah
About Saral Dinesh Shah
Data last updated:
Saral Dinesh Shah has 11 years in corporate governance. Holds Director role. Currently with 2 companies, including Novaphene Ingredients Private Limited and Novaphene Specialities Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Novaphene Specialities Private Limited at ₹117 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Apr 2015 | 1987 | ₹117 Cr (FY 2025) | Active | |
| Director | 29 Apr 2021 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saral Dinesh Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saral Dinesh Shah
Saral Dinesh Shah has 11 years in corporate governance. Holds Director role. Currently with 2 companies, including Novaphene Ingredients Private Limited and Novaphene Specialities Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Novaphene Specialities Private Limited at ₹117 Cr (FY 2025).
Saral Dinesh Shah is associated with 2 companies as Director, including Novaphene Specialities Private Limited (₹117 Cr), Novaphene Ingredients Private Limited.
Saral Dinesh Shah has expertise in General Business.
Saral Dinesh Shah has 11 years in corporate governance.
By reported revenue, the largest current company of Saral Dinesh Shah is Novaphene Specialities Private Limited, with revenue of ₹117 Cr (FY 2025).
Saral Dinesh Shah currently holds positions at 2 companies: Novaphene Specialities Private Limited (₹117 Cr), Novaphene Ingredients Private Limited.